Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer, Secondary cancers
Closed
Phase 3
This trial is comparing giredestrant and palbociclib with letrozole and palbociclib for breast cancer.
It is open to people with breast cancer that has many oestrogen receptors (). The people taking part also have cancer that had spread into the surrounding tissue or to another part of the body.
Recruitment start: 16 March 2021
Recruitment end: 28 February 2023
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Catherine Harper-Wynne
Roche
Last reviewed: 3 March 2023
CRUK internal database number: 17442
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
